- Home »
- Research and Technology »
- Clinical Research »
- Open Trials
Open Trials
Gastrointestinal
RTOG 0436 - A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer who are treated without surgery
Prostate
RTOG 0815 - A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short- Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer
Lung
ECOG 1505 - A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB-IIIA NSCLC
ECOG 5508 - Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevaciaumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced NSCLC
ACOSOG Z4099 - A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) vs. Stereotactic Body Radiation Therapy in High Risk Patients with Stage I NSCLC (Approval still Pending)
Head/Neck
RTOG 0920 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer
Brain Metastases
RTOG 0933 A Phase II Trial of Hippocampal Avoidance during Whole Brain Radiotherapy for Brain Metastases
Breast
NSABP B 43 A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2+ Ductal Carcinoma In Situ Resected by Lumpectomy
CALGB 40601 Randomized Phase III Trial of Paclitaxel combined with Trastuzumab, Lapatinib, or Both as Neoadjuvant Treatment of Her2+ Primary Breast Cancer
Non-Therapeutic
Precision Therapuetic PT-207 Precision Therapeutic Registry Chemoresponse Assay in Solid Tumors
Diagnostic
ACRIN (American College of Radiology Imaging Network) NOPR Trial - Sodium Floride Bone Mets
ACRIN (American College of Radiology Imaging Network) NOPR Trial - The National Oncologic PET Registry—Center for Medicare and Medicaid Services to expand coverage for PET emission tomography to include cancer indications not currently covered







2500 West 12th St.